A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea
NCT ID: NCT01234168
Last Updated: 2020-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
340 participants
OBSERVATIONAL
2010-10-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with a Neuroendocrine tumour (NET) and receiving treatment with Somatuline Autogel
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ipsen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ipsen Study Director
Role: STUDY_DIRECTOR
Ipsen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Free Hospital
London, , United Kingdom
Chrisite Hospital Institute
Manchester, , United Kingdom
Freeman Hospital
Newcastle upon Tyne, , United Kingdom
Teaching Hospital Brno Bohunice
Brno, , Czechia
University Hospital Hradec Kralove
Hradec Králové, , Czechia
Hospital Pardubice
Pardubice, , Czechia
Teaching Hospital
Pilsen, , Czechia
Charles University
Prague, , Czechia
Teaching Hospital Na Bulovce
Prague, , Czechia
CHU Angers
Angers, , France
Hôpital Avicenne
Bobigny, , France
Hôpital Saint André
Bordeaux, , France
CHU Trousseau
Chambray-lès-Tours, , France
Hôpital Beaujon
Clichy, , France
CHU Michallon
Grenoble, , France
Hôpital Edouard Herriot
Lyon, , France
CHU Timone
Marseille, , France
Hôpital Archet 2
Nice, , France
Hôpital du Haut Leveque
Pessac, , France
Hôpital Robert Debré
Reims, , France
CHU St Etienne
Saint-Priest, , France
Hôpital Rangueil
Toulouse, , France
Institut Gustave-Roussy
Villejuif, , France
Semmelweis University
Budapest, , Hungary
Karádi-Nagy Bt.
Pécs, , Hungary
Hadasit Medical Research
Jerusalem, , Israel
Ospedale Regina Apostolorum
Albano Laziale, , Italy
Ospedale Pesenti Fenaroli
Alzano Lombardo, , Italy
Ospedale Civile
Castelfranco Veneto, , Italy
Università degli Studi di Chieti
Chieti, , Italy
Istituti Ospedalieri di Cremona
Cremona, , Italy
Azienda Ospedaliera-Universitaria Policlinico
Modena, , Italy
U.O.C. Malattie dell'Apparato Digerente e del Fegato
Roma, , Italy
Unità di Endocrinologia Istituti Fisioterapici Ospitalieri
Roma, , Italy
Casa Sollievo della Sofferenza
San Giovanni Rotondo, , Italy
Istituto Oncologico del Mediterraneo
Viagrande, , Italy
Szpital Uniwersytecki im. A. Jurasza
Bydgoszcz, , Poland
Slaskiego Uniwersytetu Medycznego
Katowice, , Poland
Szpital Uniwersytecki w Krakowie
Krakow, , Poland
Szpital Uniwersytecki w Lodzi
Lodz, , Poland
Prywatna Praktyka Lekarska
Olsztyn, , Poland
Specjalistyczny Gabinet Lekarski
Poznan, , Poland
Samodzielny Publiczny Szpital Kliniczny Nr 1
Szczecin, , Poland
Niepubliczny Zaklad Opieki Zdrowotnej
Warsaw, , Poland
Samodzielny Publiczny Centralny Szpital Kliniczny w Warszawie
Warsaw, , Poland
Wojskowy Instytut Medyczny
Warsaw, , Poland
Hospital Clinico Universitario de Santiago
A Coruña, , Spain
Hospital De Cruces
Barakaldo, , Spain
Hospital Universitari de Bellvitge
Barcelona, , Spain
Hospital General Reina Sofia
Córdoba, , Spain
Hospital Clinico San Carlos
Madrid, , Spain
Hospital Xeral Cies de Vigo
Pontevedra, , Spain
Hospital Virgen Macarena
Seville, , Spain
Hospital Universitario Miguel Servet
Zaragoza, , Spain
University Hospital of Wales
Cardiff, , United Kingdom
University Hospital
Coventry, , United Kingdom
University Hospital Aintree
Liverpool, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ruszniewski P, Valle JW, Lombard-Bohas C, Cuthbertson DJ, Perros P, Holubec L, Delle Fave G, Smith D, Niccoli P, Maisonobe P, Atlan P, Caplin ME; SYMNET study group. Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study. Dig Liver Dis. 2016 May;48(5):552-558. doi: 10.1016/j.dld.2015.12.013. Epub 2016 Jan 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8-79-52030-736
Identifier Type: -
Identifier Source: org_study_id